Dan A Landau

Dan A Landau

UNVERIFIED PROFILE

Are you Dan A Landau?   Register this Author

Register author
Dan A Landau

Dan A Landau

Publications by authors named "Dan A Landau"

Are you Dan A Landau?   Register this Author

20Publications

713Reads

46Profile Views

mA RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.

Cell Rep 2019 Aug;28(7):1703-1716.e6

Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.07.032DOI Listing
August 2019

TARGET-seq Takes Aim at Cancer Evolution through Multi-omics Single-Cell Genotyping and Transcriptomics.

Mol Cell 2019 03;73(6):1092-1094

Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; New York Genome Center, New York, NY, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10972765193018
Publisher Site
http://dx.doi.org/10.1016/j.molcel.2019.03.009DOI Listing
March 2019

Cancer Evolution: No Room for Negative Selection.

Cell 2017 11;171(5):987-989

Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; Division of Hematology and Medical Oncology, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA; New York Genome Center, New York, NY 10013, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.10.039DOI Listing
November 2017

Genomic complexity of multiple myeloma and its clinical implications.

Nat Rev Clin Oncol 2017 02 17;14(2):100-113. Epub 2016 Aug 17.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, HIM 237, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.122DOI Listing
February 2017

Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.

Cancer Cell 2016 Nov 3;30(5):750-763. Epub 2016 Nov 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 540, 44 Binney Street, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02141, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127278PMC
November 2016

Genetic and epigenetic determinants of B-cell lymphoma evolution.

Curr Opin Hematol 2016 07;23(4):392-401

aMeyer Cancer Center, Weill Cornell Medicine bNew York Genome Center, New York, New York, USA cInstituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000258DOI Listing
July 2016

Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.

Cancer Cell 2014 Dec;26(6):813-825

Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Division of Hematology/Oncology, Children's Hospital, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2014.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302418PMC
December 2014

Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics.

Genome Med 2013 29;5(5):47. Epub 2013 May 29.

Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706960PMC
June 2014